Paclitaxel/Carboplatin and radiation for Uterine Cancer

"In order to be included in this clinical trial, patients must be aged 18 to 99. Out of the 3735 total trials, 151 are for people under 18 and 3735 are for patients over 65."

"The information available on clinicaltrials.gov does specify that this trial is open and recruiting patients. This particular trial was first posted on May 20th, 2020 with the most recent update being November 16th, 2021. So far, only 17 individuals have been enrolled at a single site."

"Yes, the clinicaltrial.gov website verifies that this trial is still actively searching for participants. The posting date was May 20th 2020 with the most recent update on November 16th 2021. They are hoping to enroll 17 subjects from a single location."

"There are currently 1229 trials studying this treatment with 343 of them being in Phase 3. The majority of these clinical studies are based in Shanghai, but there are 67003 locations running trials for this treatment."

"Carcinoma patients between the ages of 18 and 99 are encouraged to apply for this clinical trial. In addition to carcinoma, eligible patients must also have definitive USC diagnosis determined by a previous procedure. At the discretion of the surgeon, complete surgical staging should include: total hysterectomy, bilateral salpingo-oophorectomy, peritoneal washings, omental biopsy and lymph node evaluation., ECOG performance status of ≤ 2., Residual disease at completion of surgery of ≤ 1cm by surgeon report., Age > 18 years.."

"This medication is frequently used to treat melanoma, but it can also help patients with neoplasm metastasis, lymphoma, non-hodgkin, advanced sarcoma."